Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VELIPARIB vs VENLAFAXINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VELIPARIB vs VENLAFAXINE: Safety Overview

Metric VELIPARIB VENLAFAXINE
Total FAERS Reports 391 47,931
Deaths Reported 43 7,521
Death Rate 11.0% 15.7%
Hospitalizations 222 15,749
Average Patient Age 57.9 yrs 49.5 yrs
% Female Patients 92.3% 68.7%
FDA Approval Date N/A Apr 12, 2023
Manufacturer N/A Bryant Ranch Prepack
Route N/A ORAL
Marketing Status N/A Discontinued